Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

LT antagonist/antihistamine combination highly effective against EAR/LAR

Sep. 3, 1997

ET antagonists for asthma

Sep. 2, 1997

Anti-IgE antibody inhibits allergen-induced EAR

Sep. 2, 1997

North American clinical trials with LiquiVent to be reinitiated

Sep. 1, 1997

P&U cephem derivatives for inhibiting HLE

Aug. 29, 1997

FDA approves Hi-Tech's generic promethazine/codeine syrup

Aug. 28, 1997

Hoechst Marion Roussel reports new antiallergy agents

Aug. 25, 1997

New antiallergy agents described by Dainippon Ink

Aug. 20, 1997

Tachykinin antagonist with potential as antiasthmatic

Aug. 19, 1997

Cortecs announces phase II results for Pseudostat in chronic bronchitis

Aug. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...